Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting.
about
Nanotechnology-based inhalation treatments for lung cancer: state of the artEGF receptor-targeted nanocarriers for enhanced cancer treatmentFolate decorated dual drug loaded nanoparticle: role of curcumin in enhancing therapeutic potential of nutlin-3a by reversing multidrug resistancePolymeric nanoparticles for pulmonary protein and DNA delivery.Endogenous lung surfactant inspired pH responsive nanovesicle aerosols: pulmonary compatible and site-specific drug delivery in lung metastases.Histamine-functionalized copolymer micelles as a drug delivery system in 2D and 3D models of breast cancer.Targeting tumor metastases: Drug delivery mechanisms and technologies.Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging.Interactions of nanoparticles with pulmonary structures and cellular responses.Ligand-based targeted therapy for cancer tissue.Micro- and nanocarrier-mediated lung targeting.Gateways for the intracellular access of nanocarriers: a review of receptor-mediated endocytosis mechanisms and of strategies in receptor targeting.Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.Proteins: emerging carrier for delivery of cancer therapeutics.Core-shell nanocarriers for cancer therapy. Part I: biologically oriented design rules.Recent trends in drug delivery system using protein nanoparticles.Growth factor conjugation: strategies and applications.Gelatin-based particulate systems in ocular drug delivery.Epidermal growth factor receptor is overexpressed in neuroblastoma tissues and cells.EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.Using doxorubicin and siRNA-loaded heptapeptide-conjugated nanoparticles to enhance chemosensitization in epidermal growth factor receptor high-expressed breast cancer cells.Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunitiesPreparation of magnetic gelatin nanoparticles and investigating the possible use as chemotherapeutic agent.Hardly water-soluble drug-loaded gelatin nanoparticles sustaining a slow release: preparation by novel single-step O/W/O emulsion accompanying solvent diffusion.Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics.Preparation of gelatin nanospheres incorporating quantum dots and iron oxide nanoparticles for multimodal cell imaging.Nanoparticle-cell interactions induced apoptosis: a case study with nanoconjugated epidermal growth factor.Site-specific protection and dual labeling of human epidermal growth factor (hEGF) for targeting, imaging, and cargo delivery.Improved Stability and Enhanced Oral Bioavailability of Atorvastatin Loaded Stearic Acid Modified Gelatin Nanoparticles.Development of a sensitive, stable and EGFR-specific molecular imaging agent for surface enhanced Raman spectroscopyNanoparticle-Based Drug Delivery for Therapy of Lung Cancer: Progress and Challenges
P2860
Q26774177-1A9F4E4F-BA75-4BE2-A33A-1FDD274BFDADQ27013001-E312056A-A92B-4E90-B3B9-752A0FB81E2EQ28481616-EC0CFD23-30DA-4E69-871D-3853DA7CE321Q33560960-4A402444-89D4-4D17-A4B5-5246D3C4298BQ34534060-3EDA3BBC-5F25-4C7D-8F0D-AC19D90679BBQ35741040-52229C2E-3450-4137-B83D-F6953C5EC0CFQ36557855-CAA11A38-FC84-430F-BBC8-159C9DEDBEABQ36765663-B787FFE3-9825-4B43-9D17-35F6434154ADQ37080749-9EF93E22-54C7-4C7F-A6DA-773FDA9D2FD6Q37425224-C63C3542-C9DA-41CA-BDC1-9E7F6EED7C60Q37766234-EF76AD6A-BF9E-4FB7-AF75-7AA5187F88C8Q37772516-3831AFDD-D2E5-4996-9B75-31FE57F964EBQ38067265-121E3A5B-E569-4FA7-BB3E-2CFE451600BAQ38116070-618133FB-0600-4B07-B53D-6470F5B3AA81Q38169195-B7C0896E-1114-4E1B-8ED1-ABAC78E2E746Q38199373-E67C83F7-22FB-4B66-92F9-E38038795A71Q38204731-66CBD4F7-0C94-481E-AD59-706F746157FDQ38310627-E8FF2A72-6992-4A0C-A1E8-BE440F18F778Q38761176-15E419E0-B0C7-41C4-BF1F-11EE8778FB99Q38806059-C3677E69-ECB9-4AEC-BB21-D2503647A7ADQ39129968-8AAB3808-3481-441F-B764-1183B7BDC718Q39306543-B3B0D8CA-80B2-4614-9F7F-F375C446ECB2Q44211814-F2957653-0E5F-450D-A847-8E970118D692Q47816003-8F1B4F66-C161-4A2E-BE86-E4BCBF8A5E4BQ48032111-2D0CFC22-85D7-4CA1-B525-64C44CFE9309Q51023176-C7F377EE-9531-48ED-A02E-4EFA25342C37Q51731035-9566A781-A128-4388-B6FA-7536250372FEQ51743823-4BDB8677-57EC-482B-B056-61B9A89FF5E6Q53317454-3CCAA9A2-718B-4A25-AABE-FB4878461682Q56567840-B8FBD37F-EFE4-43DE-864D-53CACC303EBCQ59019514-53C7E7A5-0675-49BA-B6B6-004900956864
P2860
Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Development of gelatin nanopar ...... ion for lung cancer targeting.
@en
type
label
Development of gelatin nanopar ...... ion for lung cancer targeting.
@en
prefLabel
Development of gelatin nanopar ...... ion for lung cancer targeting.
@en
P2093
P50
P1433
P1476
Development of gelatin nanopar ...... tion for lung cancer targeting
@en
P2093
Feng-Huei Lin
Ming-Jium Shieh
Steven Yueh-Hsiu Wu
Tai-Horng Young
Tzu-Wei Wang
P304
P356
10.1016/J.BIOMATERIALS.2007.05.006
P577
2007-05-18T00:00:00Z